Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-LepResearch in context

Summary: Background: Expansion of antimicrobial resistance monitoring and epidemiological surveillance are key components of the WHO strategy towards zero leprosy. The inability to grow Mycobacterium leprae in vitro precludes routine phenotypic drug susceptibility testing, and only limited molecula...

Full description

Bibliographic Details
Main Authors: Agathe Jouet, Sofie Marijke Braet, Cyril Gaudin, Gaëlle Bisch, Sidra Vasconcellos, Rebecca Emmanuela Epaminondas Nicacio de Oliveira do Livramento, Yrneh Yadamis Prado Palacios, Amanda Brum Fontes, Norma Lucena, Patricia Rosa, Milton Moraes, Kevin La, Nelly Badalato, Esteban Lenoir, Alice Ferré, Marie Clément, Epco Hasker, Silahi Halifa Grillone, Wirdane Abdou, Aouladi Said, Younoussa Assoumani, Nissad Attoumani, Yannick Laurent, Emmanuelle Cambau, Bouke Catherine de Jong, Philip Noël Suffys, Philip Supply
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396423002141
_version_ 1797802806763061248
author Agathe Jouet
Sofie Marijke Braet
Cyril Gaudin
Gaëlle Bisch
Sidra Vasconcellos
Rebecca Emmanuela Epaminondas Nicacio de Oliveira do Livramento
Yrneh Yadamis Prado Palacios
Amanda Brum Fontes
Norma Lucena
Patricia Rosa
Milton Moraes
Kevin La
Nelly Badalato
Esteban Lenoir
Alice Ferré
Marie Clément
Epco Hasker
Silahi Halifa Grillone
Wirdane Abdou
Aouladi Said
Younoussa Assoumani
Nissad Attoumani
Yannick Laurent
Emmanuelle Cambau
Bouke Catherine de Jong
Philip Noël Suffys
Philip Supply
author_facet Agathe Jouet
Sofie Marijke Braet
Cyril Gaudin
Gaëlle Bisch
Sidra Vasconcellos
Rebecca Emmanuela Epaminondas Nicacio de Oliveira do Livramento
Yrneh Yadamis Prado Palacios
Amanda Brum Fontes
Norma Lucena
Patricia Rosa
Milton Moraes
Kevin La
Nelly Badalato
Esteban Lenoir
Alice Ferré
Marie Clément
Epco Hasker
Silahi Halifa Grillone
Wirdane Abdou
Aouladi Said
Younoussa Assoumani
Nissad Attoumani
Yannick Laurent
Emmanuelle Cambau
Bouke Catherine de Jong
Philip Noël Suffys
Philip Supply
author_sort Agathe Jouet
collection DOAJ
description Summary: Background: Expansion of antimicrobial resistance monitoring and epidemiological surveillance are key components of the WHO strategy towards zero leprosy. The inability to grow Mycobacterium leprae in vitro precludes routine phenotypic drug susceptibility testing, and only limited molecular tests are available. We evaluated a culture-free targeted deep sequencing assay, for mycobacterial identification, genotyping based on 18 canonical SNPs and 11 core variable-number tandem-repeat (VNTR) markers, and detection of rifampicin, dapsone and fluoroquinolone resistance-associated mutations in rpoB/ctpC/ctpI, folP1, gyrA/gyrB, respectively, and hypermutation-associated mutations in nth. Methods: The limit of detection (LOD) was determined using DNA of M. leprae reference strains and from 246 skin biopsies and 74 slit skin smears of leprosy patients, with genome copies quantified by RLEP qPCR. Sequencing results were evaluated versus whole genome sequencing (WGS) data of 14 strains, and versus VNTR-fragment length analysis (FLA) results of 89 clinical specimens. Findings: The LOD for sequencing success ranged between 80 and 3000 genome copies, depending on the sample type. The LOD for minority variants was 10%. All SNPs detected in targets by WGS were identified except in a clinical sample where WGS revealed two dapsone resistance-conferring mutations instead of one by Deeplex Myc-Lep, due to partial duplication of the sulfamide-binding domain in folP1. SNPs detected uniquely by Deeplex Myc-Lep were missed by WGS due to insufficient coverage. Concordance with VNTR-FLA results was 99.4% (926/932 alleles). Interpretation: Deeplex Myc-Lep may help improve the diagnosis and surveillance of leprosy. Gene domain duplication is an original putative drug resistance-related genetic adaptation in M. leprae. Funding: EDCTP2 programme supported by the European Union (grant number RIA2017NIM-1847 -PEOPLE). EDCTP, R2Stop: Effect:Hope, The Mission To End Leprosy, the Flemish Fonds Wetenschappelijk Onderzoek.
first_indexed 2024-03-13T05:12:17Z
format Article
id doaj.art-afa44bec300b4e1ca706ecb98b36b085
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-03-13T05:12:17Z
publishDate 2023-07-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-afa44bec300b4e1ca706ecb98b36b0852023-06-16T05:10:04ZengElsevierEBioMedicine2352-39642023-07-0193104649Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-LepResearch in contextAgathe Jouet0Sofie Marijke Braet1Cyril Gaudin2Gaëlle Bisch3Sidra Vasconcellos4Rebecca Emmanuela Epaminondas Nicacio de Oliveira do Livramento5Yrneh Yadamis Prado Palacios6Amanda Brum Fontes7Norma Lucena8Patricia Rosa9Milton Moraes10Kevin La11Nelly Badalato12Esteban Lenoir13Alice Ferré14Marie Clément15Epco Hasker16Silahi Halifa Grillone17Wirdane Abdou18Aouladi Said19Younoussa Assoumani20Nissad Attoumani21Yannick Laurent22Emmanuelle Cambau23Bouke Catherine de Jong24Philip Noël Suffys25Philip Supply26GenoScreen, Lille, FranceInstitute of Tropical Medicine, Antwerp, Belgium; Department of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium; Research Foundation Flanders, Brussels, BelgiumGenoScreen, Lille, FranceGenoScreen, Lille, FranceLaboratório de Biologia Molecular Aplicada a Micobactérias, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, BrazilLaboratório de Biologia Molecular Aplicada a Micobactérias, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, BrazilLaboratório de Biologia Molecular Aplicada a Micobactérias, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, BrazilCPqAM/Fiocruz Recife, Pernambuco, BrazilCPqAM/Fiocruz Recife, Pernambuco, BrazilInstituto Lauro de Souza Lima, Bauru, São Paulo, BrazilLaboratório de Hanseníase, IOC, Fiocruz RJ, BrazilAPHP-GHU Paris Nord Hôpital Bichat, Service de mycobactériologie spécialisée et de référence, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux - Laboratoire Associé, Paris, France; Université Paris Cité, INSERM, IAME UMR1137, Paris, FranceGenoScreen, Lille, FranceGenoScreen, Lille, FranceGenoScreen, Lille, FranceGenoScreen, Lille, FranceInstitute of Tropical Medicine, Antwerp, BelgiumDamien Foundation, ComorosDamien Foundation, ComorosDamien Foundation, ComorosDamien Foundation, Comoros; National Tuberculosis and Leprosy Control Program, Moroni, ComorosDamien Foundation, ComorosGenoScreen, Lille, FranceAPHP-GHU Paris Nord Hôpital Bichat, Service de mycobactériologie spécialisée et de référence, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux - Laboratoire Associé, Paris, France; Université Paris Cité, INSERM, IAME UMR1137, Paris, FranceInstitute of Tropical Medicine, Antwerp, BelgiumLaboratório de Biologia Molecular Aplicada a Micobactérias, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, BrazilUniv. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France; Corresponding author.Summary: Background: Expansion of antimicrobial resistance monitoring and epidemiological surveillance are key components of the WHO strategy towards zero leprosy. The inability to grow Mycobacterium leprae in vitro precludes routine phenotypic drug susceptibility testing, and only limited molecular tests are available. We evaluated a culture-free targeted deep sequencing assay, for mycobacterial identification, genotyping based on 18 canonical SNPs and 11 core variable-number tandem-repeat (VNTR) markers, and detection of rifampicin, dapsone and fluoroquinolone resistance-associated mutations in rpoB/ctpC/ctpI, folP1, gyrA/gyrB, respectively, and hypermutation-associated mutations in nth. Methods: The limit of detection (LOD) was determined using DNA of M. leprae reference strains and from 246 skin biopsies and 74 slit skin smears of leprosy patients, with genome copies quantified by RLEP qPCR. Sequencing results were evaluated versus whole genome sequencing (WGS) data of 14 strains, and versus VNTR-fragment length analysis (FLA) results of 89 clinical specimens. Findings: The LOD for sequencing success ranged between 80 and 3000 genome copies, depending on the sample type. The LOD for minority variants was 10%. All SNPs detected in targets by WGS were identified except in a clinical sample where WGS revealed two dapsone resistance-conferring mutations instead of one by Deeplex Myc-Lep, due to partial duplication of the sulfamide-binding domain in folP1. SNPs detected uniquely by Deeplex Myc-Lep were missed by WGS due to insufficient coverage. Concordance with VNTR-FLA results was 99.4% (926/932 alleles). Interpretation: Deeplex Myc-Lep may help improve the diagnosis and surveillance of leprosy. Gene domain duplication is an original putative drug resistance-related genetic adaptation in M. leprae. Funding: EDCTP2 programme supported by the European Union (grant number RIA2017NIM-1847 -PEOPLE). EDCTP, R2Stop: Effect:Hope, The Mission To End Leprosy, the Flemish Fonds Wetenschappelijk Onderzoek.http://www.sciencedirect.com/science/article/pii/S2352396423002141Mycobacterium lepraeTargeted next generation sequencingAntibiotic resistanceGene domain duplicationDiagnosticsSurveillance
spellingShingle Agathe Jouet
Sofie Marijke Braet
Cyril Gaudin
Gaëlle Bisch
Sidra Vasconcellos
Rebecca Emmanuela Epaminondas Nicacio de Oliveira do Livramento
Yrneh Yadamis Prado Palacios
Amanda Brum Fontes
Norma Lucena
Patricia Rosa
Milton Moraes
Kevin La
Nelly Badalato
Esteban Lenoir
Alice Ferré
Marie Clément
Epco Hasker
Silahi Halifa Grillone
Wirdane Abdou
Aouladi Said
Younoussa Assoumani
Nissad Attoumani
Yannick Laurent
Emmanuelle Cambau
Bouke Catherine de Jong
Philip Noël Suffys
Philip Supply
Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-LepResearch in context
EBioMedicine
Mycobacterium leprae
Targeted next generation sequencing
Antibiotic resistance
Gene domain duplication
Diagnostics
Surveillance
title Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-LepResearch in context
title_full Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-LepResearch in context
title_fullStr Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-LepResearch in context
title_full_unstemmed Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-LepResearch in context
title_short Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-LepResearch in context
title_sort hi plex deep amplicon sequencing for identification high resolution genotyping and multidrug resistance prediction of mycobacterium leprae directly from patient biopsies by using deeplex myc lepresearch in context
topic Mycobacterium leprae
Targeted next generation sequencing
Antibiotic resistance
Gene domain duplication
Diagnostics
Surveillance
url http://www.sciencedirect.com/science/article/pii/S2352396423002141
work_keys_str_mv AT agathejouet hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT sofiemarijkebraet hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT cyrilgaudin hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT gaellebisch hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT sidravasconcellos hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT rebeccaemmanuelaepaminondasnicaciodeoliveiradolivramento hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT yrnehyadamispradopalacios hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT amandabrumfontes hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT normalucena hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT patriciarosa hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT miltonmoraes hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT kevinla hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT nellybadalato hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT estebanlenoir hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT aliceferre hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT marieclement hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT epcohasker hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT silahihalifagrillone hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT wirdaneabdou hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT aouladisaid hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT younoussaassoumani hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT nissadattoumani hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT yannicklaurent hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT emmanuellecambau hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT boukecatherinedejong hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT philipnoelsuffys hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext
AT philipsupply hiplexdeepampliconsequencingforidentificationhighresolutiongenotypingandmultidrugresistancepredictionofmycobacteriumlepraedirectlyfrompatientbiopsiesbyusingdeeplexmyclepresearchincontext